GEODIS, a world leader in transport and logistics, announced it has strengthened its air freight temperature-controlled pharma shipment capabilities across the Americas region by earning IATA’s Center of Excellence for Independent Validators in Pharmaceutical Logistics (CEIV Pharma) certification across seven sites in the United States, Latin America and Canada. GEODIS now has a total of 27 CEIV Pharma certified sites across its global network in the Americas, Asia Pacific and Middle East, and Europe.
Earning the CEIV Pharma accreditation supports GEODIS' strategic goals of establishing pharma healthcare as a key organizational vertical and expanding its global network by accrediting sites in numerous countries across the globe. Having this certification ensures that GEODIS’ facilities, equipment, operations and staff comply with the appropriate applicable standards, guidelines and regulations expected from a pharmaceutical manufacturer. This industry-wide standard aims to extend best practices and achieve a globally acceptable standardization. By forming a common baseline from existing regulations and standards, this certification ensures international and national compliance to safeguard product integrity while addressing specific air cargo needs in pharma logistics.

The following sites are now IATA CEIV Pharma certified across GEODIS in Americas’ network in the United States, Latin America and Canada: Chicago O'Hare International Airport, Hartsfield Jackson Atlanta International Airport, Los Angeles International Airport, Newark Liberty International Airport, Mexico City International Airport, Sao Paulo International Airport and Toronto Pearson International Airport.